Search

everythinglearnresearchcommunity

for

Search:↓

New understanding and treatments for hair loss are improving, but more research is needed.

More people are seeing dermatologists for hair and scalp problems now than in the past.

Visualizing data helps guide future androgenetic alopecia research and policies.

Some COVID-19 pneumonia patients in Veracruz, Mexico had rare skin issues like temporary hair loss linked to disease severity.

Some COVID-19 pneumonia patients in Veracruz, Mexico, had skin issues, with reversible hair loss linked to disease severity.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

Photobiomodulation helps reduce pain, lessen inflammation, heal wounds, and can be used in skin treatments. It also boosts hair growth in women with hair loss and may help fight microbes and prevent respiratory issues in COVID-19.

The document says hair loss can happen after recovering from COVID-19 and it can cause psychological discomfort.

A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.

COVID-19 diagnosis is linked to new or worsening hair diseases, with stress from the pandemic likely contributing.

COVID-19 can cause hair and nail disorders after infection.

Long COVID is more common in those with severe initial infections, but not linked to blood group.

Many COVID-19 patients have long-term symptoms, especially women, but certain medications may help reduce these symptoms.

Searches for acne, hair loss, and eczema increased during COVID-19, while searches for other skin issues decreased.

A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Hair transplantation is an effective hair loss treatment with two main techniques, requires careful planning, and can improve beard and eyebrows appearance.

COVID-19 doesn't make alopecia areata worse.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Testosterone may influence COVID-19 severity and outcomes.

Some blood thinners and blood pressure medicines can cause hair loss, which usually starts 1 to 6 months after beginning the medication.

Most men using teledermatology for hair loss treatment saw improved hair and self-esteem, with some experiencing side effects.

The study identified five types of long COVID symptoms and suggests tailored management strategies for each.

Nearly half of the studied men with long COVID had low testosterone, including younger men.

Kampo medicine can help treat general fatigue from long COVID.

COVID-19 reinfection may trigger alopecia areata.

Baricitinib helps with severe hair loss, negative-pressure therapy lowers hernia recurrence, tranexamic acid reduces bleeding, robot-assisted breast surgery may improve outcomes, and acellular dermal matrix could decrease breast reconstruction complications.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.